Research Roundup: What we’re reading this week
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
This week, the White House released President Obama’s much-anticipated budget request for fiscal year (FY) 2015. The budget request has mixed results for federal agencies that conduct global health research—including the Centers for Disease Control and Prevention, the Department of Defense, the US Food and Drug Administration, the National Institutes of Health, and the US Agency for International Development (USAID).
Pharmaceutical company Janssen announced that SIRTURO® (bedaquiline)—a new drug for the treatment of multi-drug resistant tuberculosis (TB)—has been granted conditional approval by the European Commission. The drug was approved for use as part of an appropriate combination regimen for pulmonary multi-drug resistant TB in adult patients.
USAID has released its 2013 report to Congress—Health-Related Research and Development Progress Report. The report provides an update on the agency’s global health research and development (R&D) portfolio, specifically highlighting certain technologies and disease areas.
The Kaiser Family Foundation has pulled together several news sources reports on research findings presented at the Conference on Retroviruses and Opportunistic Infections taking place in Boston this week.